Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 4/20 | 0.38 |
| ▸ | RNPEP | Q9H4A4 | 3/20 | 0.38 |
| ▸ | DNPEP | Q9ULA0 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.31 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.31 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4662744 | 0.85 | TGFBR1 (0.36) | SMN1; SMN2RAB9AGAANPC1L3MBTL1 | |
| SCHEMBL20718735 | 0.81 | ANPEP (0.32) | ANPEPRNPEPDNPEPALDH1A1CHRNB2 | |
| Hydrochloric Acid SCHEMBL406599 | 0.74 | ZDHHC20 (0.47) | GAAALDH1A1TSHR | |
| SCHEMBL6602887 | 0.71 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL11125454 | 0.69 | — | — | |
| SCHEMBL12583973 | 0.67 | CYP2C19 (0.50) | SMN1; SMN2RAB9AGAANPC1ALDH1A1 | |
| SCHEMBL14560074 | 0.67 | SMN1; SMN2 (0.55) | SMN1; SMN2RAB9AGAANPC1L3MBTL1 | |
| SCHEMBL9868278 | 0.65 | ANPEP (0.56) | SMN1; SMN2RAB9AGAANPC1L3MBTL1 | |
| SCHEMBL9182079 | 0.65 | GABRR1 (0.52) | ANPEPCYP1A2ENPEP | |
| SCHEMBL7902653 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11414531-B2 | Nucleating agents, methods for their production, and associated polymer compositions | BASF SE (DE) | 2022-08-16 | — | — | US | disclosed |
| US-20200079929-A1 | NUCLEATING AGENTS, METHODS FOR THEIR PRODUCTION, AND ASSOCIATED POLYMER COMPOSITIONS | BASF SE (DE) | 2020-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200079929-A1 | NUCLEATING AGENTS, METHODS FOR THEIR PRODUCTION, AND ASSOCIATED POLYMER COMPOSITIONS | PHOSPHO1, NCAPD2, NUP50 | SMN1; SMN2 2735/4885RAB9A 4221/4885GAA 3428/4885 |
| US-11414531-B2 | Nucleating agents, methods for their production, and associated polymer compositions | PHOSPHO1, NCAPD2, NUP50 | SMN1; SMN2 2735/4885RAB9A 4221/4885GAA 3428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.